Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

12 Months Ended

Nov. 30, 2012

Share Based Compensation Arrangement by Share Based Payment Award [Line Items]

Significant option groups outstanding and exercisable option and its price and contractual life

Significant option groups outstanding and exercisable at November 30, 2012 and related price and contractual life information are as follows:


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price

$0.42 to $1.00		10,000		2.45	$	.78		10,000	$	.78
$1.01 to $ 2.00		533,009		7.79	$	1.68		501,601	$	1.69
$2.01 to $ 3.00		599,500		7.05	$	2.51		379,505	$	2.61
$3.01 to $ 4.00		40,589		.35	$	3.34		40,589	$	3.34

		1,183,098		7.12	$	2.15		931,695	$	2.13

Summary of non-vested options

A summary of the status of the Company’s non-vested shares as of November 30, 2012, and changes during the fiscal year ended November 30, 2012, is presented below:


	Shares			Weighted Average Grant-Date Fair Value

Non-vested at November 30, 2011		353,277		$	1.94

Granted		779,500			1.57
Vested		(765,487	)		1.67
Forfeited		(115,887	)		1.65

Non-vested at November 30, 2012		251,403		$	1.77

Service-based vesting condition options [Member]

Share Based Compensation Arrangement by Share Based Payment Award [Line Items]

Fair value of options granted

Variables used to determine the fair value of the options granted for the years ended November 30, 2012 and November 30, 2011 are as follows:


	2012			2011
Weighted average values:
Expected dividends		0	%		0	%
Expected volatility		113	%		108	%
Risk free interest rate		.87	%		1.20	%
Expected life		5.5 years			5.5 years

Stock option activity for options

Stock option activity for options with only service-based vesting conditions for the year ended November 30, 2012, was as follows:


	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2011		608,419		$	2.40		6.38	$	37,490

Granted		779,500			1.93				474,765
Exercised		(33,562	)		1.83				22,801
Expired/forfeited		(171,259	)		2.10				91,830


Outstanding at November 30, 2012		1,183,098		$	2.15		7.12	$	580,730

Exercisable at November 30, 2012		931,695		$	2.13		7.42	$	493,223

Performance and market-based vesting condition options [Member]

Share Based Compensation Arrangement by Share Based Payment Award [Line Items]

Fair value of options granted

Variables used to determine the fair value of options with performance-based and market-based vesting conditions granted during the fiscal year ended November 30, 2012 are as follows:


	2012
Weighted average values:
Expected dividends		0	%
Expected volatility		107.03	%
Risk free interest rate		1.00	%
Expected life		6.4 years

Stock option activity for options

Stock option activity for options with performance-based and market-based vesting conditions for the fiscal year ended November 30, 2012, was as follows:


	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2011		—			—		—		—

Granted		1,170,000		$	1.73

Exercised		—			—
Expired/forfeited		(530,000	)		1.72


Outstanding at November 30, 2012		640,000		$	1.73		7.59	$	274,800

Exercisable at November 30, 2012		—			—		—		—

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References + Details